Enhanced antitumor effect of binimetinib in combination with capecitabine for biliary tract cancer patients with mutations in the RAS/RAF/MEK/ERK pathway: phase Ib study.
Jin Won KimKyung-Hun LeeJi-Won KimKoung Jin SuhAh-Rong NamJu-Hee BangYung-Jue BangDo-Youn OhPublished in: British journal of cancer (2019)
ClinicalTrials.gov (Identifier: NCT02773459).